Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant docetaxel for high-risk, node-negative breast cancer.
Martín M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A; GEICAM 9805 Investigators. Martín M, et al. N Engl J Med. 2010 Dec 2;363(23):2200-10. doi: 10.1056/NEJMoa0910320. N Engl J Med. 2010. PMID: 21121833 Free article. Clinical Trial.
Clinical guideline SEOM: cancer of unknown primary site.
Collado Martín R, García Palomo A, de la Cruz Merino L, Borrega García P, Barón Duarte FJ; Spanish Society for Medical Oncology. Collado Martín R, et al. Clin Transl Oncol. 2014 Dec;16(12):1091-7. doi: 10.1007/s12094-014-1244-0. Epub 2014 Nov 13. Clin Transl Oncol. 2014. PMID: 25392080 Free PMC article.
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M. Blancas I, et al. Clin Transl Oncol. 2018 Jul;20(7):862-869. doi: 10.1007/s12094-017-1797-9. Epub 2017 Nov 24. Clin Transl Oncol. 2018. PMID: 29178019
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M. Blancas I, et al. Clin Transl Oncol. 2018 Dec;20(12):1631-1632. doi: 10.1007/s12094-018-1956-7. Clin Transl Oncol. 2018. PMID: 30284231 Free article.
Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy.
García-Girón C, García Palomo A, Alonso López C, León Carbonero A, Méndez Ureña M, Adróver Cebrián E, Barceló Galíndez R, Arroyo Yustos M, Alvarez Gallego J. García-Girón C, et al. Clin Transl Oncol. 2005 Jul;7(6):244-9. doi: 10.1007/BF02710170. Clin Transl Oncol. 2005. PMID: 16131447 Clinical Trial.
The role of anthracyclines in small cell lung cancer.
López-González A, Diz P, Gutierrez L, Almagro E, García Palomo A, Provencio M. López-González A, et al. Ann Transl Med. 2013 Apr;1(1):5. doi: 10.3978/j.issn.2305-5839.2013.01.05. Ann Transl Med. 2013. PMID: 25332950 Free PMC article. Review.
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Bayo-Calero JL, Mayordomo JI, Sánchez-Rovira P, Pérez-Carrión R, Illaramendi JJ, García-Bueno JM, González-Flores E, Crespo C, Ramos-Vázquez M, García-Palomo A, Ruiz-Borrego M, de la Haba J, Gómez-Bernal A, Yubero-Esteban A. Bayo-Calero JL, et al. Clin Breast Cancer. 2008 Jun;8(3):264-8. doi: 10.3816/CBC.2008.n.030. Clin Breast Cancer. 2008. PMID: 18650157 Clinical Trial.
44 results